1. Home
  2. BIO vs KNX Comparison

BIO vs KNX Comparison

Compare BIO & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • KNX
  • Stock Information
  • Founded
  • BIO 1952
  • KNX 1989
  • Country
  • BIO United States
  • KNX United States
  • Employees
  • BIO N/A
  • KNX N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • KNX Trucking Freight/Courier Services
  • Sector
  • BIO Industrials
  • KNX Industrials
  • Exchange
  • BIO Nasdaq
  • KNX Nasdaq
  • Market Cap
  • BIO 9.1B
  • KNX 9.6B
  • IPO Year
  • BIO N/A
  • KNX 1994
  • Fundamental
  • Price
  • BIO $322.15
  • KNX $57.29
  • Analyst Decision
  • BIO Strong Buy
  • KNX Buy
  • Analyst Count
  • BIO 4
  • KNX 17
  • Target Price
  • BIO $411.00
  • KNX $56.38
  • AVG Volume (30 Days)
  • BIO 211.4K
  • KNX 2.0M
  • Earning Date
  • BIO 10-30-2024
  • KNX 10-23-2024
  • Dividend Yield
  • BIO N/A
  • KNX 1.15%
  • EPS Growth
  • BIO N/A
  • KNX N/A
  • EPS
  • BIO N/A
  • KNX 0.23
  • Revenue
  • BIO $2,580,209,000.00
  • KNX $7,477,716,000.00
  • Revenue This Year
  • BIO N/A
  • KNX $5.11
  • Revenue Next Year
  • BIO $3.61
  • KNX $5.85
  • P/E Ratio
  • BIO N/A
  • KNX $241.54
  • Revenue Growth
  • BIO N/A
  • KNX 7.54
  • 52 Week Low
  • BIO $262.12
  • KNX $45.55
  • 52 Week High
  • BIO $387.99
  • KNX $60.99
  • Technical
  • Relative Strength Index (RSI)
  • BIO 39.02
  • KNX 55.32
  • Support Level
  • BIO $306.42
  • KNX $55.24
  • Resistance Level
  • BIO $387.99
  • KNX $56.61
  • Average True Range (ATR)
  • BIO 12.82
  • KNX 1.60
  • MACD
  • BIO -5.89
  • KNX -0.12
  • Stochastic Oscillator
  • BIO 21.17
  • KNX 43.55

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About KNX Knight-Swift Transportation Holdings Inc.

Knight-Swift is the largest truckload carrier in the US, with a diversified transportation offering. Pro forma for the U.S. Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload at 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.

Share on Social Networks: